Atlas FDA

PRI

8 FDA 510(k) clearances · Product code

139 daysmedian time to decision
207 days90th percentile
8clearances measured

FDA profile

Official device name
Procalcitonin Assay
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3215
Medical specialty
Microbiology
FDA definition
To aid in decision making on antibiotic therapy, including antibiotic initiation and discontinuation, for inpatients or patients in the Emergency Department, with suspected or confirmed lower respiratory tract infections (LRTI) defined as community-acquired pneumonia (CAP), acute bronchitis, and acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
Adverse events (MAUDE)
2021: 157 · 2022: 16
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
Dimension EXL LOCI BRAHMS Procalcitonin (PCT) (K220262)Siemens Healthcare Diagnostics, Inc.2022-08-26
Elecsys BRAHMS PCT (K192815)Roche Diagnostics2020-03-09
Elecsys BRAHMS PCT (K173927)Roche Diagnostics2018-07-06
LIAISON BRAHMS PCT II GEN, LIAISON Control BRAHMS PCT II GEN, LIAISON BRAHMS PCT II GEN Verifiers (K173683)DiaSorin, Inc.2018-02-27
Lumipulse G B•R•A•H•M•S PCT Immunoreaction Cartridges, Lumipulse G B•R•A•H•M•S PCT Calibrators set (K172713)Fujirebio Diagnostics,Inc.2017-12-10
ARCHITECT B.R.A.H.M.S PCT, ARCHITECT B.R.A.H.M.S PCT Calibrators, ARCHITECT B.R.A.H.M.S PCT Controls (K170652)Fisher Diagnostics2017-06-01
B R A H M S PCT sensitive KRYPTOR (K171338)Brahms GmbH2017-05-31
VIDAS B.R.A.H.M.S. PCT (PCT) (K162827)bioMerieux, Inc.2017-02-23

Track PRI automatically

Every clearance here is in the API, with alerts when new ones post.